Senores Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	60,579	34,982	26,278	-	-	-
Market Cap Growth	153.74%	33.12%	-	-	-	-
Enterprise Value	62,712	35,572	28,923	-	-	-
Last Close Price	1315.40	759.60	570.60	-	-	-
PE Ratio	49.84	30.06	44.87	-	-	-
Forward PE	41.11	25.94	-	-	-	-
PS Ratio	9.58	5.53	6.60	-	-	-
PB Ratio	6.28	3.63	3.24	-	-	-
P/TBV Ratio	11.05	6.38	4.65	-	-	-
P/OCF Ratio	97.63	56.38	-	-	-	-
PEG Ratio	1.94	0.57	-	-	-	-
EV/Sales Ratio	9.91	5.62	7.26	-	-	-
EV/EBITDA Ratio	37.26	21.13	32.78	-	-	-
EV/EBIT Ratio	45.75	25.95	39.69	-	-	-
Debt / Equity Ratio	0.36	0.36	0.39	1.11	1.38	0.40
Debt / EBITDA Ratio	2.03	2.03	3.51	6.28	5.56	10.62
Net Debt / Equity Ratio	0.19	0.19	-0.09	1.06	1.37	0.32
Net Debt / EBITDA Ratio	1.08	1.08	-0.80	6.05	5.71	9.15
Net Debt / FCF Ratio	-0.90	-0.90	0.35	-3.16	-1.29	-0.55
Asset Turnover	0.45	0.45	0.43	0.57	0.37	-
Inventory Turnover	3.45	3.45	3.99	5.38	4.19	-
Quick Ratio	1.14	1.14	2.60	0.77	0.74	2.31
Current Ratio	1.92	1.92	3.00	1.01	0.99	2.74
Return on Equity (ROE)	13.79%	13.79%	11.18%	23.59%	20.55%	-
Return on Assets (ROA)	6.05%	6.05%	4.93%	5.24%	7.16%	-
Return on Invested Capital (ROIC)	10.39%	11.11%	9.89%	10.81%	9.46%	2.25%
Return on Capital Employed (ROCE)	11.60%	11.60%	7.40%	8.40%	13.80%	2.50%
Earnings Yield	1.92%	3.33%	2.23%	-	-	-
FCF Yield	-3.35%	-5.79%	-7.74%	-	-	-
Buyback Yield / Dilution	-21.26%	-21.26%	-41.13%	-103.16%	-131.33%	-